Vaxcell-Bio Therapeutics Logo

Vaxcell-Bio Therapeutics

Biotech firm developing immunotherapies for oncology and other diseases.

323990 | KO

Overview

Corporate Details

ISIN(s):
KR7323990002
LEI:
Country:
South Korea
Address:
전라남도 화순군 화순읍 산단길 12-55, 화순군

Description

Vaxcell-Bio Therapeutics is a biotechnology company specializing in the research and development of innovative immunotherapies. The company's primary focus is on oncology, developing a pipeline of cell-based and protein-based treatments, including immune cell therapies and targeted protein-degrading therapeutics. In addition to its core focus on cancer, Vaxcell-Bio is expanding its research into other areas, such as developing drug delivery system (DDS)-based therapies for conditions like macular degeneration.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.4 KB
2026-01-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2026-01-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2026-01-08 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 331.4 KB
2026-01-06 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 22.0 KB
2026-01-06 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-09-18 00:00
기업설명회(IR)개최
Korean HTML 6.9 KB
2025-09-17 00:00
투자판단관련주요경영사항 (박스루킨-15주 (Vaxleukin-15 inj) 품목허가 변경신청 승인)
Korean HTML 11.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.2 MB
2025-07-28 00:00
기업설명회(IR)개최
Korean HTML 7.9 KB
2025-06-24 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 126.2 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.2 MB
2025-04-15 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.2 KB
2025-04-08 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 17.0 KB
2025-04-08 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 17.1 KB

Automate Your Workflow. Get a real-time feed of all Vaxcell-Bio Therapeutics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vaxcell-Bio Therapeutics

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vaxcell-Bio Therapeutics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bone Biologics Corp Logo
Develops a protein-based bone graft substitute for spinal fusion procedures.
United States of America
BBLG
Bonyf N.V. Logo
Develops medical devices for oral, dental, orthodontic, and dermatological care.
Belgium
MLBON
Boryung Corporation Logo
A healthcare company developing pharmaceuticals and investing in health sector innovation.
South Korea
003850
Bosnalijek d.d. Sarajevo Logo
Develops, manufactures, and exports a wide range of pharmaceutical products.
Bosnia and Herzegovina
BSNL
Boule Diagnostics Logo
Provider of hematology systems for decentralized human and veterinary markets.
Sweden
BOUL
Boundless Bio, Inc. Logo
Clinical-stage oncology company targeting ecDNA in oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma developing inhibitors for genetically driven cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Develops selective serotonin agonists for neurological and psychiatric disorders.
United States of America
DRUG
A clinical-stage biopharma company developing cancer immunotherapies and cell therapies.
Japan
4594

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.